Volume 34, Issue 6 (September 2023)
Studies in Medical Sciences 2023, 34(6): 308-320 |
Back to browse issues page
Ethics code: IR-UU-AEC-3/5
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Zeinali Z, Abtahi Froushani S M, Ownagh A, Zamani A. THE SYNERGISM OF THE COMBINED GLYCYRRHIZIC ACID AND ALUM LIPOSOME ON IMMUNE RESPONSES AGAINST THE KILLED FORM OF SALMONELLA TYPHIMURIUM. Studies in Medical Sciences 2023; 34 (6) :308-320
URL: http://umj.umsu.ac.ir/article-1-5994-en.html
URL: http://umj.umsu.ac.ir/article-1-5994-en.html
AssociatProfessor of Immunology, Department of Microbiology, Faculty of Veterinary Medicine, Urmia University, Urmia, Iran , sm.abtahi@hotmail.com
Abstract: (1174 Views)
Background & Aims: The killed preparation of microorganisms in combination with alum does not generally produce strong cellular immune responses. Glycyrrhizic acid is a triterpenoid saponin with immunomodulating properties. The present study was conducted to investigate the synergism of glycyrrhizic acid (GL) and alum liposome on immune responses against the killed form of Salmonella Typhimurium (HKST).
Materials & Methods: In this experimental study, male Balb/c mice in 5 groups of 15 were immunized with HKST vaccine alone or in combination with alum, GL or alum-GL combination twice with two weeks’ interval. Fourteen days after the last vaccination, the immune responses against Salmonella Typhimurium and the protective potential of the vaccines were evaluated. Survival rate was monitored by Kaplan-Meier analysis. Other findings were analyzed using one-way analysis of variance and Tukey's post hoc test. A level of P<0.05 was considered significant.
Results: Delayed type hypersensitivity reaction, lymphocyte proliferation, IgG2a antibody titer and the rate of improvement of survival against challenge with live were significantly increased in the group receiving combined adjuvant and HKST compared to other groups. In the group receiving combined adjuvant, the level of IFN-γ significantly increased and IL-4 significantly decreased more profound than other groups.
Conclusion: Alum-GL combination as an adjuvant synergistically increased cellular and humoral immunity after immunization with the HKST vaccine.
Materials & Methods: In this experimental study, male Balb/c mice in 5 groups of 15 were immunized with HKST vaccine alone or in combination with alum, GL or alum-GL combination twice with two weeks’ interval. Fourteen days after the last vaccination, the immune responses against Salmonella Typhimurium and the protective potential of the vaccines were evaluated. Survival rate was monitored by Kaplan-Meier analysis. Other findings were analyzed using one-way analysis of variance and Tukey's post hoc test. A level of P<0.05 was considered significant.
Results: Delayed type hypersensitivity reaction, lymphocyte proliferation, IgG2a antibody titer and the rate of improvement of survival against challenge with live were significantly increased in the group receiving combined adjuvant and HKST compared to other groups. In the group receiving combined adjuvant, the level of IFN-γ significantly increased and IL-4 significantly decreased more profound than other groups.
Conclusion: Alum-GL combination as an adjuvant synergistically increased cellular and humoral immunity after immunization with the HKST vaccine.
Type of Study: Research |
Subject:
ایمونولوژی
References
1. Andre FE, Booy R, Bock HL, Clemens J, Datta SK, John TJ, et al. Vaccination greatly reduces disease, disability, death and inequity worldwide. Bull World Health Organ 2008;86(2):140-6. [DOI:10.2471/BLT.07.040089] [PMID] [PMCID]
2. Reed SG, Bertholet S, Coler RN, Friede M. New horizons in adjuvants for vaccine development. Trends Immunol 2009;30(1):23-32. [DOI:10.1016/j.it.2008.09.006] [PMID]
3. Mazloomi E, Jazani NH, Shahabi S. A novel adjuvant, mixture of alum and the beta-adrenergic receptor antagonist propranolol, elicits both humoral and cellular immune responses for heat-killed Salmonella typhimurium vaccine. Vaccine 2012;30(16):2640-6. [DOI:10.1016/j.vaccine.2012.02.017] [PMID]
4. Takaya A, Yamamoto T, Tokoyoda K. Humoral immunity vs. Salmonella. Front Immunol 2020; 10: 3155. [DOI:10.3389/fimmu.2019.03155] [PMID] [PMCID]
5. Eneslätt K, Golovliov I, Rydén P, Sjöstedt A. Vaccine-mediated mechanisms controlling replication of Francisella tularensis in human peripheral blood mononuclear cells using a co-culture system. Front Cell Infect Microbiol 2018;8:27. [DOI:10.3389/fcimb.2018.00027] [PMID] [PMCID]
6. Chan J, Mehta S, Bharrhan S, Chen Y, Achkar JM, Casadevall A, et al., editors. The role of B cells and humoral immunity in Mycobacterium tuberculosis infection. Cell Infect 2014: Elsevier. [DOI:10.1016/j.smim.2014.10.005] [PMID] [PMCID]
7. Bastola R, Noh G, Keum T, Bashyal S, Seo J-E, Choi J, et al. Vaccine adjuvants: smart components to boost the immune system. Arch Pharm Res 2017;40(11):1238-48. [DOI:10.1007/s12272-017-0969-z] [PMID]
8. Burakova Y, Madera R, McVey S, Schlup JR, Shi J. Adjuvants for animal vaccines. Viral Immunol 2018;31(1):11-22. [DOI:10.1089/vim.2017.0049] [PMID]
9. Ye Y, Chen F, Sun H, Li X, Xu S. Stemucronatoside K, a novel C21 steroidal glycoside from Stephanotis mucronata, inhibited the cellular and humoral immune response in mice. Int. Immunopharmacol 2008;8(9):1231-8. [DOI:10.1016/j.intimp.2008.04.014] [PMID]
10. Zhao X, Fan Y, Wang D, Hu Y, Guo L, Ruan S, et al. Immunological adjuvant efficacy of glycyrrhetinic acid liposome against Newcastle disease vaccine. Vaccine 2011;29(52):9611-7. [DOI:10.1016/j.vaccine.2011.10.053] [PMID]
11. Abe N, Ebina T, Ishida N. Interferon induction by glycyrrhizin and glycyrrhetinic acid in mice. Microbiol Immunol 1982;26(6):535-9. [DOI:10.1111/j.1348-0421.1982.tb00207.x] [PMID]
12. Gløgård C, Stensrud G, Hovland R, Fossheim SL, Klaveness J. Liposomes as carriers of amphiphilic gadolinium chelates: the effect of membrane composition on incorporation efficacy and in vitro relaxivity. Int J Pharm 2002;233(1-2):131-40. [DOI:10.1016/S0378-5173(01)00935-8] [PMID]
13. Gregoriadis G, Gursel I, Gursel M, McCormack B. Liposomes as immunological adjuvants and vaccine carriers. J Control Release 1996;41(1-2):49-56. [DOI:10.1016/0168-3659(96)01355-7]
14. Perrie Y, Crofts F, Devitt A, Griffiths HR, Kastner E, Nadella V. Designing liposomal adjuvants for the next generation of vaccines. Adv Drug Deliv Rev 2016;99:85-96. [DOI:10.1016/j.addr.2015.11.005] [PMID]
15. Gregoriadis G. Immunological adjuvants: a role for liposomes. Immunol Today 1990;11(3):89-97 [DOI:10.1016/0167-5699(90)90034-7] [PMID]
16. Mohammadi A, Abtahi Froushani SM, DelireZh N, Ownagh A. Alum and metoclopramide synergistically enhance cellular and humoral immunity after immunization with heat-killed Salmonella typhimurium vaccine. Int Immunopharmacol 2021;101(Pt A):108185 [DOI:10.1016/j.intimp.2021.108185] [PMID]
17. Jazani NH, Parsania S, Sohrabpour M, Mazloomi E, Karimzad M, Shahabi S. Naloxone and alum synergistically augment adjuvant activities of each other in a mouse vaccine model of Salmonella typhimurium infection. Immunobiology 2011;216(6):744-51. [DOI:10.1016/j.imbio.2010.10.005] [PMID]
18. Ghimire TR. The mechanisms of action of vaccines containing aluminum adjuvants: an in vitro vs in vivo paradigm. Springerplus 2015;4(1):1-18. [DOI:10.1186/s40064-015-0972-0] [PMID] [PMCID]
19. Abtahi Froushani SM, Delirezh N, Hobbenaghi R, Mosayebi G. Synergistic effects of atorvastatin and all-trans retinoic acid in ameliorating animal model of multiple sclerosis. Immunol Invest 2014;43(1):54-68. [DOI:10.3109/08820139.2013.825269] [PMID]
20. Golbahari S, Froushani SMA. Synergistic benefits of nicotine and thymol in alleviating experimental rheumatoid arthritis. Life Sci 2019;239:117037. [DOI:10.1016/j.lfs.2019.117037] [PMID]
21. Kool M, Fierens K, Lambrecht BN. Alum adjuvant: some of the tricks of the oldest adjuvant. Int J Med Microbiol 2012;61(7):927-34. [DOI:10.1099/jmm.0.038943-0] [PMID]
22. Harte C, Gorman AL, McCluskey S, Carty M, Bowie AG, Scott C, et al. Alum activates the bovine NLRP3 inflammasome. Front Immunol 2017;8:1494. [DOI:10.3389/fimmu.2017.01494] [PMID] [PMCID]
23. Shushtari N, Froushani SMA. Caffeine augments the instruction of anti-inflammatory macrophages by the conditioned medium of mesenchymal stem cells. Cell J (Yakhteh) 2017;19(3):415. [PMCID]
24. Orecchioni M, Ghosheh Y, Pramod AB, Ley K. Macrophage polarization: different gene signatures in M1 (LPS+) vs. classically and M2 (LPS-) vs. alternatively activated macrophages. Front Immunol 2019;10:1084. [DOI:10.3389/fimmu.2019.01084] [PMID] [PMCID]
25. Richard SA. Exploring the pivotal immunomodulatory and anti-inflammatory potentials of glycyrrhizic and glycyrrhetinic acids. Mediators Inflamm 2021;2021. [DOI:10.1155/2021/6699560] [PMID] [PMCID]
26. Froushani SMA, Galeh HEG. New insight into the immunomodulatory mechanisms of Tretinoin in NMRI mice. Iran J Basic Med Sci 2014;17(9):632. [PMCID]
27. Muraille E, Leo O, Moser M. TH1/TH2 paradigm extended: macrophage polarization as an unappreciated pathogen-driven escape mechanism? Front Immunol 2014;5:603. [DOI:10.3389/fimmu.2014.00603]
28. Moriyama M, Nakamura S. Th1/Th2 immune balance and other T helper subsets in IgG4-related disease. Curr Top Microbiol Immunol 2017;401:75-83. [DOI:10.1007/82_2016_40] [PMID]
29. Cêtre C, Pierrot C, Cocude C, Lafitte S, Capron A, Capron M, et al. Profiles of Th1 and Th2 cytokines after primary and secondary infection by Schistosoma mansoni in the semipermissive rat host. Infect Immun 1999;67(6):2713-9. [DOI:10.1128/IAI.67.6.2713-2719.1999] [PMID] [PMCID]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
